Nathan Rakieten
- Endocrinology, Diabetes and Metabolism top 5%
- Molecular Biology
- Surgery top 10%
- Physiology top 10%
- Genetics
- Co-authors
- Morris L. RakietenPhilip S. ScheinDavid A. CooneyBenjamin S. GordonDavid P. RallRobert P. KlettRuth D. DavisJames P. Chovan
- Topics
- Pancreatic function and diabetes (3 papers)Neuroendocrine Tumor Research Advances (2 papers)Pharmacological Effects of Natural Compounds (2 papers)
- Journals
- Journal of Pharmacology and Experimental TherapeuticsJournal of Pharmaceutical SciencesToxicology and Applied Pharmacology
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Nathan Rakieten
18 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Endocrinology, Diabetes and Metabolism 424
- Molecular Biology 396
- Surgery 367
- Physiology 234
- Genetics 162
Countries citing papers authored by Nathan Rakieten
This map shows the geographic impact of Nathan Rakieten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Rakieten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Rakieten more than expected).
Fields of papers citing papers by Nathan Rakieten
This network shows the impact of papers produced by Nathan Rakieten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Rakieten. The network helps show where Nathan Rakieten may publish in the future.
Co-authorship network of co-authors of Nathan Rakieten
This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Rakieten. A scholar is included among the top collaborators of Nathan Rakieten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Rakieten. Nathan Rakieten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | Metastatic renal adenocarcinoma produced by streptozotocin (NSC-85998). | 4 |
| 5 | 28 | |
| 6 | 14 | |
| 7 | 103 | |
| 8 | 7 | |
| 9 | The toxicity of Escherichia coli L-asparaginase. | 35 |
| 10 | Renal tumorigenic action of streptozotocin (NSC-85998) in rats. | 33 |
| 11 | Studies on the diabetogenic action of streptozotocinbreakdown → | 731 |
| 12 | Studies on the diabetogenic action of streptozotocin (NSC-37917). | 242 |
| 13 | The diabetogenic action of streptozocin | 2 |
| 14 | 7 | |
| 15 | 2 | |
| 16 | 8 | |
| 17 | 10 | |
| 18 | 12 | |
| 19 | 8 |
About Nathan Rakieten
Nathan Rakieten is a scholar working on Transplantation, Pharmacology and Nephrology, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (424 citations), Clinical Biochemistry (69 citations) and Biochemistry (57 citations). Nathan Rakieten has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Morris L. Rakieten, Philip S. Schein, David A. Cooney, Benjamin S. Gordon, David P. Rall, Robert P. Klett, Ruth D. Davis, James P. Chovan, James H. Birnie and Jay Tepperman. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Pharmaceutical Sciences and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.